Revista de Investigación Clínica (Jan 2022)

The microbiota-gut-brain axis: clinical applications in obesity and type 2 diabetes

  • Brandy Moser,
  • Megan A. Milligan,
  • Maria C. Dao

DOI
https://doi.org/10.24875/RIC.22000197
Journal volume & issue
Vol. 74, no. 6

Abstract

Read online

Recent investigations highlight the importance of the gut microbiota and bacteria-derived metabolites as key components in obesity and metabolic health. The microbiota-gut-brain axis presents promising targets for future obesity treatments and prevention. However, the current state of evidence and existing clinical applications of the microbiota-gut-brain axis have yet to be summarized in a thorough review. Therefore, we sought to examine current evidence on the effect of lifestyle, dietary, pharmacological, and surgical interventions on the microbiota-gut-brain axis. In addition, this review highlights potential next steps in research toward characterizing the role of the microbiota-gut-brain axis in metabolic health, along with possible interventions to address obesity.

Keywords